19 Einträge gefunden

1. Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma

   1. Mai, Elias K
   2. Huhn, Stefanie
   3. Miah, Kaya
   4. Poos, Alexandra M
   5. Scheid, Christof
   6. Weisel, Katja C
   7. Bertsch, Uta

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Patients With Multiple Myeloma or Monoclonal Gammopathy of Undetermined Significance

   1. Piechotta, Vanessa
   2. Skoetz, Nicole
   3. Engelhardt, Monika
   4. Einsele, Hermann
   5. Goldschmidt, Hartmut
   6. Scheid, Christof

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. MM-183 CARTITUDE-2 Cohort A: Updated Clinical Data and Biological Correlative Analyses of Ciltacabtagene Autoleucel (cilta-cel) in Lenalidomide-Refractory Patients With Progressive Multiple Myeloma (MM) After 1-3 Prior Lines of Therapy (LOT)

   1. Hillengass, Jens
   2. Cohen, Adam D
   3. Delforge, Michel
   4. Einsele, Hermann
   5. Goldschmidt, Hartmut
   6. Weisel, Katja
   7. Raab, Marc-Steffen

   2022 - Forschungsinformationssystem des UKE
4. Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age

   1. Mai, Elias K
   2. Miah, Kaya
   3. Bertsch, Uta
   4. Dürig, Jan
   5. Scheid, Christof
   6. Weisel, Katja C
   7. Kunz, Christina

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. Evaluation of six different types of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory acute myelogenous leukemia - a study of the Acute Leukemia Working Party of the EBMT

   1. Heinicke, Thomas
   2. Labopin, Myriam
   3. Polge, Emmanuelle
   4. Stelljes, Matthias
   5. Ganser, Arnold
   6. Tischer, Johanna
   7. Brecht, Arne

   2021 - Forschungsinformationssystem des UKE
6. Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial

   1. Salwender, Hans
   2. Elmaagacli, Ahmet
   3. Merz, Maximilian
   4. Miah, Kaya
   5. Benner, Axel
   6. Haenel, Mathias
   7. Jehn, Christian

   2021 - Forschungsinformationssystem des UKE
7. Autologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effects

   1. Jansen, Lina
   2. Merz, Maximilian
   3. Engelhardt, Monika
   4. Weisel, Katja
   5. Scheid, Christof
   6. Straka, Christian
   7. Langer, Christian

   2020 - Forschungsinformationssystem des UKE
8. Response-adapted lenalidomide maintenance in newly diagnosed myeloma:results from the phase III GMMG-MM5 trial

   1. Goldschmidt, Hartmut
   2. Mai, Elias K
   3. Dürig, Jan
   4. Scheid, Christof
   5. Weisel, Katja C
   6. Kunz, Christina
   7. Bertsch, Uta

   2020 - Forschungsinformationssystem des UKE
9. Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party

   1. Bazarbachi, Abdul Hamid
   2. Al Hamed, Rama
   3. Labopin, Myriam
   4. Afanasyev, Boris
   5. Hamladji, Rose-Marie
   6. Beelen, Dietrich
   7. Eder, Matthias

   2020 - Forschungsinformationssystem des UKE
10. Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia

    1. Michallet, Mauricette
    2. Dreger, Peter
    3. Sobh, Mohamad
    4. Koster, Linda
    5. Hoek, Jennifer
    6. Boumendil, Ariane
    7. Scheid, Christof

    2020 - Forschungsinformationssystem des UKE
11. Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD

    1. Jagasia, Madan
    2. Scheid, Christof
    3. Socié, Gérard
    4. Ayuk, Francis Ayuketang
    5. Tischer, Johanna
    6. Donato, Michele L
    7. Bátai, Árpád

    2019 - Forschungsinformationssystem des UKE
12. Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

    1. Dreger, Peter
    2. Michallet, Mauricette
    3. Bosman, Paul
    4. Dietrich, Sascha
    5. Sobh, Mohamad
    6. Boumendil, Ariane
    7. Nagler, Arnon

    2019 - Forschungsinformationssystem des UKE
13. Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial

    1. Weisel, Katja C
    2. Scheid, Christof
    3. Zago, Manola
    4. Besemer, Britta
    5. Mai, Elias K
    6. Haenel, Mathias
    7. Duerig, Jan

    2019 - Forschungsinformationssystem des UKE
14. Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)

    1. Kröger, Nicolaus
    2. Iacobelli, Simona
    3. Franke, Georg-Nikolaus
    4. Platzbecker, Uwe
    5. Uddin, Ruzena
    6. Hübel, Kai
    7. Scheid, Christof

    2017 - Forschungsinformationssystem des UKE
15. Treatment options for relapse after autograft in multiple myeloma - report from an EBMT educational meeting

    1. Garderet, Laurent
    2. Cook, Gordon
    3. Auner, Holger W
    4. Bruno, Benedetto
    5. Lokhorst, Henk
    6. Perez-Simon, Jose Antonio
    7. Sahebi, Firoozeh

    2017 - Forschungsinformationssystem des UKE
16. Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation

    1. Koenecke, Christian
    2. Göhring, Gudrun
    3. de Wreede, Liesbeth C
    4. van Biezen, Anja
    5. Scheid, Christof
    6. Volin, Liisa
    7. Maertens, Johan

    2015 - Forschungsinformationssystem des UKE - frei zugänglich
17. Granulocyte-colony stimulating factor response is superior to neutropenia duration in predicting the risk of infection after high-dose chemotherapy for myeloma and lymphoma

    1. Straka, Christian
    2. Salwender, Hans
    3. Schnabel, Brigitte
    4. Sandherr, Michael
    5. Wandt, Hannes
    6. Hübel, Kai
    7. Scheid, Christof

    2015 - Forschungsinformationssystem des UKE
18. Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia

    1. Pfirrmann, Markus
    2. Saussele, Susanne
    3. Hochhaus, Andreas
    4. Reiter, Andreas
    5. Berger, Ute
    6. Hossfeld, Dieter K
    7. Nerl, Christoph

    2014 - Forschungsinformationssystem des UKE
19. Allogeneic hematopoietic stem cell transplantation: an option for long-term survival for patients with simultaneous appearance of myeloid and lymphatic malignancies.

    1. Weber, Thomas
    2. Ocheni, Sunday
    3. Binder, Mascha
    4. Theurich, Sebastian
    5. Scheid, Christof
    6. Schmid, Christoph
    7. Müller, Lutz Peter

    2013 - Forschungsinformationssystem des UKE